Berntorp E - Search Results

1

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Schwarz J, Astermark J, Menius ED, Carrington M, Donfield SM, Gomperts ED, Nelson GW, Oldenburg J, Pavlova A, Shapiro AD, Winkler CA, Berntorp E; Hemophilia Inhibitor Genetics Study Combined Cohort. Schwarz J, et al. Among authors: berntorp e. Haemophilia. 2013 Jan;19(1):113-8. doi: 10.1111/hae.12004. Epub 2012 Sep 7. Haemophilia. 2013. PMID: 22958194 Free PMC article.

2

No effect of a new second-generation B-domain-deleted recombinant product on lymphocyte transformation in vitro: a study of plasma-derived and recombinant products.

Astermark J, Ekman M, Berntorp E. Astermark J, et al. Among authors: berntorp e. Br J Haematol. 1997 Nov;99(2):289-94. doi: 10.1046/j.1365-2141.1997.4153222.x. Br J Haematol. 1997. PMID: 9375741 Free article.

3

[Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates].

Astermark J, Berntorp E, Stigendal L, Johnsson H. Astermark J, et al. Among authors: berntorp e. Lakartidningen. 1998 Jan 7;95(1-2):48-50. Lakartidningen. 1998. PMID: 9458646 Swedish.

4

The Malmö-Klaipeda WFH twinning programme: a comparative description of the haemophilia cohorts.

Berntorp E, Astermark J, Jurgutis R, Lethagen S, Petersson C. Berntorp E, et al. Haemophilia. 1998 Mar;4(2):79-82. doi: 10.1046/j.1365-2516.1998.00169.x. Haemophilia. 1998. PMID: 9873842 Clinical Trial.

5

Malmö International Brother Study (MIBS): an international survey of brother pairs with haemophilia.

Astermark J, Berntorp E. Astermark J, et al. Among authors: berntorp e. Vox Sang. 1999;77 Suppl 1:80-2. doi: 10.1159/000056723. Vox Sang. 1999. PMID: 10529695

6

The Malmö model for immune tolerance induction: impact of previous treatment on outcome.

Carlborg E, Astermark J, Lethagen S, Ljung R, Berntorp E. Carlborg E, et al. Among authors: berntorp e. Haemophilia. 2000 Nov;6(6):639-42. doi: 10.1046/j.1365-2516.2000.00436.x. Haemophilia. 2000. PMID: 11122389

7

Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.

Berntorp E, Astermark J, Carlborg E. Berntorp E, et al. Haematologica. 2000 Oct;85(10 Suppl):48-50; discussion 50-1. Haematologica. 2000. PMID: 11187871

8

Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis.

Björkman S, Shapiro AD, Berntorp E. Björkman S, et al. Among authors: berntorp e. Haemophilia. 2001 Mar;7(2):133-9. doi: 10.1046/j.1365-2516.2001.00465.x. Haemophilia. 2001. PMID: 11260271

9

Anti- and procoagulant activities in factor VII-deficient subjects.

Astermark J, Tengborn L, Hedner U, Berntorp E. Astermark J, et al. Among authors: berntorp e. Thromb Res. 2001 Mar 15;101(6):435-40. doi: 10.1016/s0049-3848(00)00410-2. Thromb Res. 2001. PMID: 11323000

10

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients.

Astermark J, Berntorp E, White GC, Kroner BL; MIBS Study Group. Astermark J, et al. Among authors: berntorp e. Haemophilia. 2001 May;7(3):267-72. doi: 10.1046/j.1365-2516.2001.00510.x. Haemophilia. 2001. PMID: 11380630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

388 results

Search Page

Filters